Urate oxidase

The product is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding was cloned from a strain of Aspergillus flavus. Urate oxidase https://www.creativebiomart.net/therapeutic-proteins/p/91/recombinant-urate-oxidase-enzyme/

The product is a recombinant, B-domain deleted, porcine sequence antihaemophilic factor VIII (FVIII). Susoctocog alfa https://www.creativebiomart.net/therapeutic-proteins/p/93/recombinant-b-domain-deleted-porcine-sequence-antihaemophilic-factor-viii-fviii/

The product is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). Structurally, the product is a glycosylated fusion protein with a MALDI-MS molecular weight of 92,300 Da and it is a homodimer of two homologous polypeptide chains of 357 amino acids each. It is produced through recombinant DNA technology in mammalian CHO cells. The drug has activity as a selective co-stimulation modulator with inhibitory activity on T lymphocytes. Nulojix https://www.creativebiomart.net/therapeutic-proteins/p/102/fusion-protein-of-human-ctla-4-and-igg1/

Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD Interferon beta-1b https://www.creativebiomart.net/therapeutic-proteins/p/103/human-interferon-beta-165-residues/